BSX · 10-Q · 2026Q2 · Full report

Trade Policy and Tariffs

BOSTON SCIENTIFIC CORP · 2026-08-03 · Importance 37 · Surprise 42

Boston Scientific cites significant uncertainty in global trade policies, including changing tariff rates, delayed tariff impositions and potential reciprocal restrictions by the U.S. or other governments. The company expects possible higher distribution costs and supply-chain disruptions from global conflicts and energy-market volatility, with the timing and magnitude uncertain. In the second quarter and first six months of 2026, gross margin benefited from recovery of previously incurred tariffs imposed under the International Emergency Economic Powers Act (IEEPA), including an $83 million pre-tax benefit and $77 million after-tax benefit recognized in cost of products sold.